Annovis Bio, Inc. (ANVS)
NYSE · Healthcare
Annovis Bio, Inc. Shareholder Equity 2020–2025
Annovis Bio, Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Annovis Bio, Inc. shareholder equity for the quarter ending December 31, 2025 were 16.9M, a 81.05% increase year-over-year.
- Annovis Bio, Inc. shareholder equity for 2025 were 16.9M, a 81.05% increase from 2024.
- Annovis Bio, Inc. shareholder equity for 2024 were 9.3M, a 220.09% decrease from 2023.
- Annovis Bio, Inc. shareholder equity for 2023 were -7.8M, a 127.37% decrease from 2022.
- Annovis Bio, Inc. shareholder equity for 2022 were 28.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Annovis Bio, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $17 |
| 2024 | $9 |
| 2023 | $-8 |
| 2022 | $28 |
| 2021 | $44 |
| 2020 | $8 |
| Annovis Bio, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $17 |
| 2024-12-31 | $9 |
| 2023-12-31 | $-8 |
| 2022-12-31 | $28 |
| 2021-12-31 | $44 |
| 2020-12-31 | $8 |
Annovis Bio, Inc. Shareholder Equity — FAQ
Annovis Bio, Inc. (ANVS) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANVS's shareholder equity history?
The chart and table above show Annovis Bio, Inc.'s shareholder equity by year and by quarter, including the growth rate.